OpenAlex
PricingAboutJobs
Log inGet started
Work

Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Endocrinology & Metabolism
DOI: 10.1210/jc.2012-4018
Authors: John P. Bilezikian, Robert G. Josse, Richard Eastell, E. Michael Lewiecki, Colin G. Miller, Margaret Wooddell, Allison R. Northcutt, Barbara G. Kravitz, Gitanjali Paul, Alexander R. Cobitz, Antonio J. Nino, Lorraine A. Fitzpatrick
Institutions: Columbia University, St. Michael's Hospital, University of Toronto, University of Sheffield, University of New Mexico, New Mexico Clinical Research & Osteoporosis Center, BioClinica (United States), GlaxoSmithKline (United States)
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rosiglitazone, thiazolidinediones, bone mineral density, bone turnover markers, postmenopausal women, type 2 diabetes, metformin, femoral neck, hip bone loss, lumbar spine, fracture risk, drug discontinuation
SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, BioClinica, Novo Nordisk, Servier
OpenAlex ID: W1982888437
FWCI: 13.99
Cites: 55
Cited by: 105
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security